$70.02 +2.49 (%) Alkermes PLC - NASDAQ

Jul. 31, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's M&A Chatter for Tuesday June 16, 2015

    Benzinga | Jun. 16, 2015 | 18:04PM EST
  2. US Stock Futures Decline Ahead Of Housing Starts Report

    Benzinga | Jun. 16, 2015 | 07:22AM EST
  3. Alkermes to Present Data From Late-Stage CNS Portfolio at Upcoming American Society of Clinical Psychopharmacology Annual Meeting

    Benzinga | Jun. 16, 2015 | 07:01AM EST
  4. Alkermes Reports Phase 3 Study Results for Aripiprazole Lauroxil Published in JCP

    Benzinga | Jun. 9, 2015 | 16:01PM EST
  5. US Stock Futures Edge Lower; GDP Report In Focus

    Benzinga | May. 29, 2015 | 07:47AM EST
  6. Alkermes to Present Clinical Data on ALKS 8700 at Annual Meeting of the Consortium of Multiple Sclerosis Centers

    Benzinga | May. 29, 2015 | 07:05AM EST
  7. Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest EPS Growth Forecast For Next 5 Years

    Benzinga | May. 26, 2015 | 04:15AM EST
  8. Benzinga's Top Initiations

    Benzinga | May. 21, 2015 | 09:07AM EST
  9. Barclays Initiates Alkermes With Overweight

    Benzinga | May. 21, 2015 | 08:49AM EST
  10. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | Mar. 2, 2015 | 07:36AM EST
  11. Stocks Mostly Higher: Time Warner Clears Buy Point

    IBD | Feb. 24, 2015 | 14:53PM EST
  12. Why Citigroup Placed An $85 Price Target On Shares Of Alkermes

    Benzinga | Jan. 14, 2015 | 14:37PM EST
  13. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  14. Alkermes pops to 15-year high

    IBD | Jan. 7, 2015 | 18:51PM EST
  15. Alkermes Hits High On Schizophrenia Drug Results

    IBD | Jan. 7, 2015 | 12:03PM EST
  16. Morning Market Gainers

    Benzinga | Jan. 7, 2015 | 09:38AM EST
  17. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 7, 2015 | 08:10AM EST
  18. Benzinga's Volume Movers

    Benzinga | Jan. 6, 2015 | 10:45AM EST
  19. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  20. Top 4 Stocks In The Drug Delivery Industry With The Highest Revenue

    Benzinga | Nov. 11, 2014 | 04:15AM EST
  21. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  22. Alkermes Announces Completion Of Patient Enrollment In Phase 2 Study Of ALKS 3831, A Novel, Broad-Spectrum Oral Antipsychotic

    Benzinga | Sep. 3, 2014 | 07:04AM EST
  23. US Stock Futures Rise Ahead Of Economic Data

    Benzinga | Aug. 25, 2014 | 07:28AM EST
  24. Morgan Stanley Sees EPS Below Consensus, Robust Pipeline For Alkermes plc

    Benzinga | Aug. 14, 2014 | 09:40AM EST
  25. Top 4 NASDAQ Stocks In The Drug Delivery Industry With The Highest Revenue

    Benzinga | Apr. 30, 2014 | 07:32AM EST
  26. Alkermes' drug passes trial

    IBD | Apr. 8, 2014 | 18:54PM EST
  27. Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins

    Benzinga | Apr. 8, 2014 | 16:54PM EST
  28. Stocks Rise, Led By Tech Stocks, But Volume Fades

    IBD | Apr. 8, 2014 | 16:21PM EST
  29. Mid-Afternoon Market Update: Markets Recover Slightly as Coal Shows Strength

    Benzinga | Apr. 8, 2014 | 15:46PM EST
  30. Mid-Day Market Update: US Stocks Gain; Gigamon Shares Dip On Lower Forecast

    Benzinga | Apr. 8, 2014 | 13:22PM EST
  31. Alkermes' Schizophrenia Drug Passes Trial; Filing In Q3

    IBD | Apr. 8, 2014 | 12:12PM EST
  32. Benzinga's Volume Movers

    Benzinga | Apr. 8, 2014 | 10:55AM EST
  33. Mid-Morning Market Update: Markets Mixed; A. Schulman Lifts Profit Outlook

    Benzinga | Apr. 8, 2014 | 10:29AM EST
  34. Morning Market Movers

    Benzinga | Apr. 8, 2014 | 09:38AM EST
  35. Alkermes Announces Positive Topline Results From Pivotal Phase 3 Study of Aripiprazole Lauroxil

    Benzinga | Apr. 8, 2014 | 07:01AM EST
  36. Benzinga's Top Initiations

    Benzinga | Apr. 2, 2014 | 07:49AM EST
  37. Nasdaq Back Above Water; Green Plains Jumps

    IBD | Mar. 21, 2014 | 11:54AM EST
  38. LifeLock, YY Among 5 Stocks With Top Fundamentals

    IBD | Feb. 20, 2014 | 08:02AM EST
  39. Stocks Fall In Higher Volume; Yandex, Twitter Drop

    IBD | Feb. 19, 2014 | 16:21PM EST
  40. Stocks Weaken After Fed Minutes; Thor Rallies

    IBD | Feb. 19, 2014 | 14:53PM EST
  41. Stocks End Short Week With Big Losses

    IBD | Jan. 24, 2014 | 17:03PM EST
  42. Alkermes Announces Advances in Late-Stage CNS Pipeline

    Benzinga | Jan. 8, 2014 | 07:02AM EST
  43. Alkermes Receives Notice of Allowance of US Patent for Novel Fumarate Prodrug for MS

    Benzinga | Jan. 6, 2014 | 07:04AM EST
  44. Ireland Home To Several Fast Growing Health Care Names

    IBD | Dec. 24, 2013 | 17:02PM EST
  45. Alkermes Presents Data on Aripiprazole Lauroxil and ALKS 5461 at 52nd Annual ACNP Meeting

    Benzinga | Dec. 9, 2013 | 07:13AM EST
  46. UPDATE: Citigroup Raises PT on Alkermes on Multiple Value Opportunities

    Benzinga | Oct. 17, 2013 | 09:26AM EST
  47. Alkermes, FDA Agree on Deal for Elements of ALKS 5461 Development Program

    Benzinga | Oct. 9, 2013 | 07:05AM EST
  48. Top 4 Stocks In The Drug Delivery Industry With The Highest Cash

    Benzinga | Sep. 20, 2013 | 04:16AM EST
  49. Acceleron Pharma IPO Pops; Fate Therapeutics On Deck

    IBD | Sep. 19, 2013 | 13:58PM EST
  50. Google, LKQ, Tesla: Stocks A Marsico Manager Likes

    IBD | Aug. 5, 2013 | 18:01PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!